HEADER MEMBRANE PROTEIN 19-JAN-18 6FJ3 TITLE HIGH RESOLUTION CRYSTAL STRUCTURE OF PARATHYROID HORMONE 1 RECEPTOR IN TITLE 2 COMPLEX WITH A PEPTIDE AGONIST. CAVEAT 6FJ3 FUC C 6 HAS WRONG CHIRALITY AT ATOM C1 FUC D 4 HAS WRONG CAVEAT 2 6FJ3 CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PARATHYROID HORMONE/PARATHYROID HORMONE-RELATED PEPTIDE COMPND 3 RECEPTOR,PARATHYROID HORMONE/PARATHYROID HORMONE-RELATED PEPTIDE COMPND 4 RECEPTOR,GLGA GLYCOGEN SYNTHASE,PARATHYROID HORMONE/PARATHYROID COMPND 5 HORMONE-RELATED PEPTIDE RECEPTOR; COMPND 6 CHAIN: A; COMPND 7 SYNONYM: PTH/PTHRP TYPE I RECEPTOR,PTH/PTHR RECEPTOR,PARATHYROID COMPND 8 HORMONE 1 RECEPTOR,PTH1 RECEPTOR,PTH/PTHRP TYPE I RECEPTOR,PTH/PTHR COMPND 9 RECEPTOR,PARATHYROID HORMONE 1 RECEPTOR,PTH1 RECEPTOR,GLYCOGEN COMPND 10 SYNTHASE,PTH/PTHRP TYPE I RECEPTOR,PTH/PTHR RECEPTOR,PARATHYROID COMPND 11 HORMONE 1 RECEPTOR,PTH1 RECEPTOR; COMPND 12 ENGINEERED: YES; COMPND 13 MUTATION: YES; COMPND 14 MOL_ID: 2; COMPND 15 MOLECULE: PARATHYROID HORMONE; COMPND 16 CHAIN: B; COMPND 17 SYNONYM: PTH,PARATHYRIN; COMPND 18 ENGINEERED: YES; COMPND 19 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, PYROCOCCUS ABYSSI (STRAIN GE5 / SOURCE 3 ORSAY); SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606, 272844; SOURCE 6 STRAIN: GE5 / ORSAY; SOURCE 7 GENE: PTH1R, PTHR, PTHR1, PAB2292; SOURCE 8 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS EXPRESSION VECTOR SOURCE 11 PFASTBAC1-HM; SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: EQUUS CABALLUS; SOURCE 14 ORGANISM_COMMON: HORSE; SOURCE 15 ORGANISM_TAXID: 9796; SOURCE 16 GENE: PTH; SOURCE 17 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS EXPRESSION VECTOR SOURCE 20 PFASTBAC1-HM KEYWDS GPCR, CELL SIGNALLING, 7TM, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.EHRENMANN,J.SCHOPPE,C.KLENK,M.RAPPAS,L.KUMMER,A.S.DORE,A.PLUCKTHUN REVDAT 5 17-JAN-24 6FJ3 1 HETSYN LINK REVDAT 4 29-JUL-20 6FJ3 1 CAVEAT COMPND REMARK HETNAM REVDAT 4 2 1 LINK SITE ATOM REVDAT 3 19-DEC-18 6FJ3 1 JRNL REVDAT 2 28-NOV-18 6FJ3 1 JRNL REVDAT 1 21-NOV-18 6FJ3 0 JRNL AUTH J.EHRENMANN,J.SCHOPPE,C.KLENK,M.RAPPAS,L.KUMMER,A.S.DORE, JRNL AUTH 2 A.PLUCKTHUN JRNL TITL HIGH-RESOLUTION CRYSTAL STRUCTURE OF PARATHYROID HORMONE 1 JRNL TITL 2 RECEPTOR IN COMPLEX WITH A PEPTIDE AGONIST. JRNL REF NAT. STRUCT. MOL. BIOL. V. 25 1086 2018 JRNL REFN ESSN 1545-9985 JRNL PMID 30455434 JRNL DOI 10.1038/S41594-018-0151-4 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.13_2998: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.39 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.970 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 33645 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.920 REMARK 3 FREE R VALUE TEST SET COUNT : 1657 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.3955 - 5.7211 1.00 2683 135 0.1955 0.2587 REMARK 3 2 5.7211 - 4.5420 1.00 2665 135 0.1826 0.2135 REMARK 3 3 4.5420 - 3.9681 1.00 2672 120 0.1728 0.1645 REMARK 3 4 3.9681 - 3.6054 1.00 2675 142 0.1748 0.2009 REMARK 3 5 3.6054 - 3.3471 1.00 2663 150 0.2050 0.2478 REMARK 3 6 3.3471 - 3.1498 1.00 2649 134 0.2234 0.2728 REMARK 3 7 3.1498 - 2.9921 0.99 2694 136 0.2325 0.2733 REMARK 3 8 2.9921 - 2.8618 1.00 2669 146 0.2485 0.3115 REMARK 3 9 2.8618 - 2.7517 1.00 2638 136 0.2668 0.3510 REMARK 3 10 2.7517 - 2.6567 1.00 2660 148 0.2817 0.3187 REMARK 3 11 2.6567 - 2.5737 1.00 2660 130 0.3080 0.3545 REMARK 3 12 2.5737 - 2.5001 0.99 2660 145 0.3570 0.3937 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.380 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.730 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.93 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 5310 REMARK 3 ANGLE : 0.506 7147 REMARK 3 CHIRALITY : 0.038 801 REMARK 3 PLANARITY : 0.003 856 REMARK 3 DIHEDRAL : 13.816 3146 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 31 THROUGH 162 ) REMARK 3 ORIGIN FOR THE GROUP (A): 56.5263-116.8187 248.7511 REMARK 3 T TENSOR REMARK 3 T11: 0.3642 T22: 0.3282 REMARK 3 T33: 0.4235 T12: -0.0345 REMARK 3 T13: -0.0283 T23: 0.0841 REMARK 3 L TENSOR REMARK 3 L11: 3.6676 L22: 5.9585 REMARK 3 L33: 4.3386 L12: 0.4077 REMARK 3 L13: -0.2575 L23: 0.4031 REMARK 3 S TENSOR REMARK 3 S11: 0.0559 S12: 0.3170 S13: 0.3081 REMARK 3 S21: -0.0037 S22: 0.1429 S23: 0.0920 REMARK 3 S31: -0.4497 S32: 0.4464 S33: -0.1965 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 163 THROUGH 211 ) REMARK 3 ORIGIN FOR THE GROUP (A): 52.2381-126.6211 212.3274 REMARK 3 T TENSOR REMARK 3 T11: 1.5131 T22: 1.0779 REMARK 3 T33: 0.6428 T12: 0.1376 REMARK 3 T13: 0.0137 T23: 0.1680 REMARK 3 L TENSOR REMARK 3 L11: 0.3120 L22: 0.0107 REMARK 3 L33: 4.2341 L12: -0.3164 REMARK 3 L13: -1.3435 L23: 0.8801 REMARK 3 S TENSOR REMARK 3 S11: -0.2549 S12: 0.5358 S13: -0.1250 REMARK 3 S21: -0.3632 S22: -0.3832 S23: 0.2084 REMARK 3 S31: 1.8862 S32: -0.8520 S33: -0.3294 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 212 THROUGH 480 ) REMARK 3 ORIGIN FOR THE GROUP (A): 46.5901-111.2984 170.6847 REMARK 3 T TENSOR REMARK 3 T11: 0.5759 T22: 0.5160 REMARK 3 T33: 0.3659 T12: 0.0528 REMARK 3 T13: 0.0342 T23: -0.0056 REMARK 3 L TENSOR REMARK 3 L11: 1.2328 L22: 0.8306 REMARK 3 L33: 3.8228 L12: -0.0736 REMARK 3 L13: 0.5005 L23: -0.6154 REMARK 3 S TENSOR REMARK 3 S11: -0.0276 S12: -0.3740 S13: -0.0386 REMARK 3 S21: 0.3459 S22: -0.0916 S23: -0.0194 REMARK 3 S31: 0.3351 S32: 0.5727 S33: 0.1002 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN 'B' AND (RESID 2 THROUGH 34 ) REMARK 3 ORIGIN FOR THE GROUP (A): 56.2808-122.4542 225.5416 REMARK 3 T TENSOR REMARK 3 T11: 1.0358 T22: 1.2162 REMARK 3 T33: 0.4526 T12: 0.0746 REMARK 3 T13: -0.0156 T23: 0.0124 REMARK 3 L TENSOR REMARK 3 L11: 0.5240 L22: 0.4626 REMARK 3 L33: 2.1384 L12: -0.4268 REMARK 3 L13: 1.0669 L23: -0.9001 REMARK 3 S TENSOR REMARK 3 S11: 0.2755 S12: 1.2053 S13: -0.0911 REMARK 3 S21: -0.7917 S22: 0.0193 S23: -0.2271 REMARK 3 S31: 0.8530 S32: 0.2489 S33: -0.3575 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6FJ3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-JAN-18. REMARK 100 THE DEPOSITION ID IS D_1200008418. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-SEP-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : LN2 COOLED FIXED EXIT SI(111) REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33759 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 49.390 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.15300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 1.66200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5EE7, 3C4M REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM CITRATE PH 6.0, 0.3 M REMARK 280 SODIUM ACETATE, 31% PEG400, 20 UM E-PTH(1-34), LIPIDIC CUBIC REMARK 280 PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 33160 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 22 REMARK 465 PRO A 23 REMARK 465 ALA A 24 REMARK 465 LEU A 25 REMARK 465 VAL A 26 REMARK 465 ASP A 27 REMARK 465 ALA A 28 REMARK 465 ASP A 29 REMARK 465 ASP A 30 REMARK 465 GLY A 247 REMARK 465 ALA A 248 REMARK 465 THR A 249 REMARK 465 LEU A 250 REMARK 465 ASP A 251 REMARK 465 GLU A 252 REMARK 465 ALA A 253 REMARK 465 GLU A 254 REMARK 465 ARG A 255 REMARK 465 LEU A 256 REMARK 465 THR A 257 REMARK 465 GLU A 258 REMARK 465 GLU A 259 REMARK 465 GLU A 260 REMARK 465 LEU A 261 REMARK 465 ARG A 262 REMARK 465 ALA A 263 REMARK 465 ILE A 264 REMARK 465 ALA A 265 REMARK 465 GLN A 266 REMARK 465 ALA A 267 REMARK 465 PRO A 268 REMARK 465 PRO A 269 REMARK 465 PRO A 270 REMARK 465 PRO A 271 REMARK 465 ALA A 272 REMARK 465 THR A 273 REMARK 465 ALA A 274 REMARK 465 ALA A 275 REMARK 465 ALA A 276 REMARK 465 GLY A 277 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O4 NAG E 2 O5 BMA E 3 2.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TYR B 34 C NH2 B 35 N -0.272 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 114 -10.43 84.28 REMARK 500 ILE A 115 -50.16 -126.47 REMARK 500 PHE A 173 31.47 -87.67 REMARK 500 GLU A 177 -129.27 58.44 REMARK 500 ALA A 347 -156.08 -163.88 REMARK 500 THR A 349 -165.20 -79.98 REMARK 500 ASP A 353 56.25 -96.00 REMARK 500 GLN A1262 -77.60 -133.92 REMARK 500 PRO A1335 49.50 -92.41 REMARK 500 CYS A 460 -60.76 -140.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1740 DISTANCE = 5.81 ANGSTROMS REMARK 525 HOH A1741 DISTANCE = 5.93 ANGSTROMS REMARK 525 HOH A1742 DISTANCE = 5.99 ANGSTROMS REMARK 525 HOH A1743 DISTANCE = 6.09 ANGSTROMS REMARK 525 HOH A1744 DISTANCE = 6.89 ANGSTROMS REMARK 525 HOH A1745 DISTANCE = 8.22 ANGSTROMS REMARK 525 HOH A1746 DISTANCE = 9.14 ANGSTROMS REMARK 525 HOH A1747 DISTANCE = 9.21 ANGSTROMS REMARK 525 HOH A1748 DISTANCE = 10.28 ANGSTROMS REMARK 525 HOH B 108 DISTANCE = 6.85 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 MAN A 1511 REMARK 610 MAN A 1516 REMARK 610 MAN A 1517 REMARK 610 OLA A 1518 REMARK 610 OLA A 1519 REMARK 610 OLA A 1520 REMARK 610 OLA A 1523 REMARK 610 OLA A 1524 DBREF 6FJ3 A 24 60 UNP Q03431 PTH1R_HUMAN 24 60 DBREF 6FJ3 A 105 388 UNP Q03431 PTH1R_HUMAN 105 388 DBREF 6FJ3 A 1218 1413 UNP Q9V2J8 Q9V2J8_PYRAB 218 413 DBREF 6FJ3 A 398 480 UNP Q03431 PTH1R_HUMAN 398 480 DBREF 6FJ3 B 1 34 UNP Q27IM2 PTHY_HORSE 32 65 SEQADV 6FJ3 GLY A 22 UNP Q03431 EXPRESSION TAG SEQADV 6FJ3 PRO A 23 UNP Q03431 EXPRESSION TAG SEQADV 6FJ3 CYS A 191 UNP Q03431 TYR 191 ENGINEERED MUTATION SEQADV 6FJ3 MET A 240 UNP Q03431 LYS 240 ENGINEERED MUTATION SEQADV 6FJ3 ALA A 300 UNP Q03431 LEU 300 ENGINEERED MUTATION SEQADV 6FJ3 LYS A 312 UNP Q03431 MET 312 ENGINEERED MUTATION SEQADV 6FJ3 ILE A 334 UNP Q03431 VAL 334 ENGINEERED MUTATION SEQADV 6FJ3 ASN A 359 UNP Q03431 LYS 359 ENGINEERED MUTATION SEQADV 6FJ3 ALA A 407 UNP Q03431 LEU 407 ENGINEERED MUTATION SEQADV 6FJ3 LEU A 426 UNP Q03431 ALA 426 ENGINEERED MUTATION SEQADV 6FJ3 ARG A 440 UNP Q03431 GLN 440 ENGINEERED MUTATION SEQADV 6FJ3 ALA A 458 UNP Q03431 ILE 458 ENGINEERED MUTATION SEQADV 6FJ3 AC5 B 1 UNP Q27IM2 SER 32 CONFLICT SEQADV 6FJ3 AIB B 3 UNP Q27IM2 SER 34 CONFLICT SEQADV 6FJ3 GLN B 10 UNP Q27IM2 ASN 41 ENGINEERED MUTATION SEQADV 6FJ3 HRG B 11 UNP Q27IM2 LEU 42 CONFLICT SEQADV 6FJ3 ALA B 12 UNP Q27IM2 GLY 43 ENGINEERED MUTATION SEQADV 6FJ3 TRP B 14 UNP Q27IM2 HIS 45 ENGINEERED MUTATION SEQADV 6FJ3 NLE B 18 UNP Q27IM2 VAL 49 CONFLICT SEQADV 6FJ3 TYR B 34 UNP Q27IM2 PHE 65 ENGINEERED MUTATION SEQADV 6FJ3 NH2 B 35 UNP Q27IM2 AMIDATION SEQRES 1 A 602 GLY PRO ALA LEU VAL ASP ALA ASP ASP VAL MET THR LYS SEQRES 2 A 602 GLU GLU GLN ILE PHE LEU LEU HIS ARG ALA GLN ALA GLN SEQRES 3 A 602 CYS GLU LYS ARG LEU LYS GLU VAL LEU GLN ARG PRO ALA SEQRES 4 A 602 GLY ARG PRO CYS LEU PRO GLU TRP ASP HIS ILE LEU CYS SEQRES 5 A 602 TRP PRO LEU GLY ALA PRO GLY GLU VAL VAL ALA VAL PRO SEQRES 6 A 602 CYS PRO ASP TYR ILE TYR ASP PHE ASN HIS LYS GLY HIS SEQRES 7 A 602 ALA TYR ARG ARG CYS ASP ARG ASN GLY SER TRP GLU LEU SEQRES 8 A 602 VAL PRO GLY HIS ASN ARG THR TRP ALA ASN TYR SER GLU SEQRES 9 A 602 CYS VAL LYS PHE LEU THR ASN GLU THR ARG GLU ARG GLU SEQRES 10 A 602 VAL PHE ASP ARG LEU GLY MET ILE CYS THR VAL GLY TYR SEQRES 11 A 602 SER VAL SER LEU ALA SER LEU THR VAL ALA VAL LEU ILE SEQRES 12 A 602 LEU ALA TYR PHE ARG ARG LEU HIS CYS THR ARG ASN TYR SEQRES 13 A 602 ILE HIS MET HIS LEU PHE LEU SER PHE MET LEU ARG ALA SEQRES 14 A 602 VAL SER ILE PHE VAL MET ASP ALA VAL LEU TYR SER GLY SEQRES 15 A 602 ALA THR LEU ASP GLU ALA GLU ARG LEU THR GLU GLU GLU SEQRES 16 A 602 LEU ARG ALA ILE ALA GLN ALA PRO PRO PRO PRO ALA THR SEQRES 17 A 602 ALA ALA ALA GLY TYR ALA GLY CYS ARG VAL ALA VAL THR SEQRES 18 A 602 PHE PHE LEU TYR PHE LEU ALA THR ASN TYR TYR TRP ILE SEQRES 19 A 602 ALA VAL GLU GLY LEU TYR LEU HIS SER LEU ILE PHE LYS SEQRES 20 A 602 ALA PHE PHE SER GLU LYS LYS TYR LEU TRP GLY PHE THR SEQRES 21 A 602 VAL PHE GLY TRP GLY LEU PRO ALA ILE PHE VAL ALA VAL SEQRES 22 A 602 TRP VAL SER VAL ARG ALA THR LEU ALA ASN THR GLY CYS SEQRES 23 A 602 TRP ASP LEU SER SER GLY ASN ASN LYS TRP ILE ILE GLN SEQRES 24 A 602 VAL PRO ILE LEU ALA SER ILE VAL LEU ASN PHE ILE LEU SEQRES 25 A 602 PHE ILE ASN ILE VAL ARG VAL LEU ALA THR LYS GLY ILE SEQRES 26 A 602 ASP YCM SER PHE TRP ASN GLU SER TYR LEU THR GLY SER SEQRES 27 A 602 ARG ASP GLU ARG LYS LYS SER LEU LEU SER LYS PHE GLY SEQRES 28 A 602 MET ASP GLU GLY VAL THR PHE MET PHE ILE GLY ARG PHE SEQRES 29 A 602 ASP ARG GLY GLN LYS GLY VAL ASP VAL LEU LEU LYS ALA SEQRES 30 A 602 ILE GLU ILE LEU SER SER LYS LYS GLU PHE GLN GLU MET SEQRES 31 A 602 ARG PHE ILE ILE ILE GLY LYS GLY ASP PRO GLU LEU GLU SEQRES 32 A 602 GLY TRP ALA ARG SER LEU GLU GLU LYS HIS GLY ASN VAL SEQRES 33 A 602 LYS VAL ILE THR GLU MET LEU SER ARG GLU PHE VAL ARG SEQRES 34 A 602 GLU LEU TYR GLY SER VAL ASP PHE VAL ILE ILE PRO SER SEQRES 35 A 602 TYR PHE GLU PRO PHE GLY LEU VAL ALA LEU GLU ALA MET SEQRES 36 A 602 CYS LEU GLY ALA ILE PRO ILE ALA SER ALA VAL GLY GLY SEQRES 37 A 602 LEU ARG ASP ILE ILE THR ASN GLU THR GLY ILE LEU VAL SEQRES 38 A 602 LYS ALA GLY ASP PRO GLY GLU LEU ALA ASN ALA ILE LEU SEQRES 39 A 602 LYS ALA LEU GLU LEU SER ARG SER ASP LEU SER LYS PHE SEQRES 40 A 602 ARG GLU ASN CYS LYS LYS ARG ALA MET SER PHE SER ASP SEQRES 41 A 602 THR ARG GLN GLN TYR ARG LYS LEU ALA LYS SER THR LEU SEQRES 42 A 602 VAL LEU MET PRO LEU PHE GLY VAL HIS TYR ILE VAL PHE SEQRES 43 A 602 MET LEU THR PRO TYR THR GLU VAL SER GLY THR LEU TRP SEQRES 44 A 602 GLN VAL ARG MET HIS TYR GLU MET LEU PHE ASN SER PHE SEQRES 45 A 602 GLN GLY PHE PHE VAL ALA ILE ALA TYR CYS PHE CYS ASN SEQRES 46 A 602 GLY GLU VAL GLN ALA GLU ILE LYS LYS SER TRP SER ARG SEQRES 47 A 602 TRP THR LEU ALA SEQRES 1 B 35 AC5 VAL AIB GLU ILE GLN LEU MET HIS GLN HRG ALA LYS SEQRES 2 B 35 TRP LEU ASN SER NLE GLU ARG VAL GLU TRP LEU ARG LYS SEQRES 3 B 35 LYS LEU GLN ASP VAL HIS ASN TYR NH2 MODRES 6FJ3 YCM A 1221 CYS MODIFIED RESIDUE HET YCM A1221 10 HET AC5 B 1 8 HET AIB B 3 6 HET HRG B 11 12 HET NLE B 18 8 HET NH2 B 35 1 HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET MAN C 4 11 HET MAN C 5 11 HET FUC C 6 10 HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET FUC D 4 10 HET NAG E 1 14 HET NAG E 2 14 HET BMA E 3 11 HET MAN E 4 11 HET MAN A1511 11 HET MAN A1516 11 HET MAN A1517 11 HET OLA A1518 9 HET OLA A1519 11 HET OLA A1520 7 HET OLA A1521 20 HET OLA A1522 20 HET OLA A1523 7 HET OLA A1524 13 HET OLA A1525 20 HET OLA A1526 20 HET ACY A1527 4 HET PG4 A1528 13 HET CL A1529 1 HETNAM YCM S-(2-AMINO-2-OXOETHYL)-L-CYSTEINE HETNAM AC5 1-AMINOCYCLOPENTANECARBOXYLIC ACID HETNAM AIB ALPHA-AMINOISOBUTYRIC ACID HETNAM HRG L-HOMOARGININE HETNAM NLE NORLEUCINE HETNAM NH2 AMINO GROUP HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM OLA OLEIC ACID HETNAM ACY ACETIC ACID HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM CL CHLORIDE ION HETSYN YCM CYSTEINE-S-ACETAMIDE HETSYN AC5 CYCLO-LEUCINE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 1 YCM C5 H10 N2 O3 S FORMUL 2 AC5 C6 H11 N O2 FORMUL 2 AIB C4 H9 N O2 FORMUL 2 HRG C7 H16 N4 O2 FORMUL 2 NLE C6 H13 N O2 FORMUL 2 NH2 H2 N FORMUL 3 NAG 6(C8 H15 N O6) FORMUL 3 BMA 3(C6 H12 O6) FORMUL 3 MAN 6(C6 H12 O6) FORMUL 3 FUC 2(C6 H12 O5) FORMUL 9 OLA 9(C18 H34 O2) FORMUL 18 ACY C2 H4 O2 FORMUL 19 PG4 C8 H18 O5 FORMUL 20 CL CL 1- FORMUL 21 HOH *156(H2 O) HELIX 1 AA1 THR A 33 GLN A 57 1 25 HELIX 2 AA2 ARG A 179 PHE A 212 1 34 HELIX 3 AA3 ARG A 213 HIS A 216 5 4 HELIX 4 AA4 CYS A 217 SER A 246 1 30 HELIX 5 AA5 ALA A 279 LYS A 312 1 34 HELIX 6 AA6 SER A 316 ALA A 347 1 32 HELIX 7 AA7 GLY A 357 ASN A 359 5 3 HELIX 8 AA8 LYS A 360 ARG A 383 1 24 HELIX 9 AA9 ASN A 1225 LEU A 1229 5 5 HELIX 10 AB1 SER A 1232 PHE A 1244 1 13 HELIX 11 AB2 GLY A 1264 SER A 1277 1 14 HELIX 12 AB3 LYS A 1278 GLN A 1282 5 5 HELIX 13 AB4 ASP A 1293 HIS A 1307 1 15 HELIX 14 AB5 SER A 1318 GLY A 1327 1 10 HELIX 15 AB6 GLY A 1342 LEU A 1351 1 10 HELIX 16 AB7 VAL A 1360 ILE A 1367 1 8 HELIX 17 AB8 ASP A 1379 ARG A 1395 1 17 HELIX 18 AB9 LEU A 1398 THR A 427 1 46 HELIX 19 AC1 GLY A 434 PHE A 450 1 17 HELIX 20 AC2 PHE A 450 CYS A 460 1 11 HELIX 21 AC3 ASN A 463 THR A 478 1 16 HELIX 22 AC4 VAL B 2 TYR B 34 1 33 SHEET 1 AA1 2 VAL A 126 PRO A 130 0 SHEET 2 AA1 2 HIS A 143 ARG A 147 -1 O ALA A 144 N VAL A 129 SHEET 1 AA2 6 VAL A1310 ILE A1313 0 SHEET 2 AA2 6 MET A1284 ILE A1289 1 N ILE A1288 O LYS A1311 SHEET 3 AA2 6 VAL A1250 ILE A1255 1 N PHE A1252 O ARG A1285 SHEET 4 AA2 6 PHE A1331 ILE A1334 1 O ILE A1333 N MET A1253 SHEET 5 AA2 6 ILE A1354 SER A1358 1 O ILE A1356 N VAL A1332 SHEET 6 AA2 6 ILE A1373 VAL A1375 1 O ILE A1373 N ALA A1357 SSBOND 1 CYS A 48 CYS A 117 1555 1555 2.03 SSBOND 2 CYS A 108 CYS A 148 1555 1555 2.03 SSBOND 3 CYS A 131 CYS A 170 1555 1555 2.03 SSBOND 4 CYS A 281 CYS A 351 1555 1555 2.03 LINK ND2 ASN A 151 C1 NAG E 1 1555 1555 1.43 LINK ND2 ASN A 161 C1 NAG C 1 1555 1555 1.46 LINK ND2 ASN A 166 C1 NAG D 1 1555 1555 1.46 LINK C ASP A1220 N YCM A1221 1555 1555 1.33 LINK C YCM A1221 N SER A1222 1555 1555 1.33 LINK C AC5 B 1 N VAL B 2 1555 1555 1.28 LINK C VAL B 2 N AIB B 3 1555 1555 1.33 LINK C AIB B 3 N GLU B 4 1555 1555 1.33 LINK C GLN B 10 N HRG B 11 1555 1555 1.33 LINK C HRG B 11 N ALA B 12 1555 1555 1.33 LINK C SER B 17 N NLE B 18 1555 1555 1.33 LINK C NLE B 18 N GLU B 19 1555 1555 1.33 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.41 LINK O6 NAG C 1 C1 FUC C 6 1555 1555 1.41 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.41 LINK O3 BMA C 3 C1 MAN C 4 1555 1555 1.48 LINK O6 BMA C 3 C1 MAN C 5 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.44 LINK O6 NAG D 1 C1 FUC D 4 1555 1555 1.47 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.43 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.47 LINK O4 NAG E 2 C1 BMA E 3 1555 1555 1.45 LINK O6 BMA E 3 C1 MAN E 4 1555 1555 1.46 CRYST1 44.115 52.864 111.874 80.63 83.76 79.16 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022668 -0.004342 -0.001865 0.00000 SCALE2 0.000000 0.019260 -0.002840 0.00000 SCALE3 0.000000 0.000000 0.009089 0.00000